Skin autofluorescence predicts cancer in subjects with type 2 diabetes.
Ninon FoussardAlice LarroumetMarine RigoKamel MohammediLaurence Baillet-BlancoPauline PouponMarie MonlunMaxime LecocqAnne-Claire DevougeClaire DucosMarion LiebartQuentin BattagliniVincent RigalleauPublished in: BMJ open diabetes research & care (2021)
Skin autofluorescence, a potential marker of glycemic memory, predicts the occurrence of cancer in subjects with type 2 diabetes. This relation provides a new clinical argument for the role of AGEs in cancer. Their estimation by measuring the skin autofluorescence may help select subjects with diabetes in cancer screening programs.